ZuzanaTothovaMD

Hematologic Oncology

Clinical Fellow in Medicine, Dana-Farber Cancer Institute

Dr. Tothova is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
450 Brookline Avenue, D0259
Boston, MA 02115
Phone+1 617-632-2933

Fax+1 617-632-2933

Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2011 - 2014
Brigham and Women's HospitalResidency, Internal Medicine, 2009 - 2011
Harvard Medical SchoolClass of 2009

PubMed

Steering research on mRNA splicing in cancer towards clinical translation.
Olga Anczukow, Frédéric H-T Allain, Brittany L Angarola, Douglas L Black, Angela N Brooks
Nature Reviews. Cancer. 2024-12-01
1 citations
Subunit-specific analysis of cohesin-mutant myeloid malignancies reveals distinct ontogeny and outcomes.
Johann-Christoph Jann, Christopher B Hergott, Marisa Winkler, Yiwen Liu, Benjamin Braun
Leukemia. 2024-09-01
8 citations
Splicing modulators impair DNA damage response and induce killing of cohesin-mutant MDS and AML.
Emily C Wheeler, Benjamin J E Martin, William C Doyle, Sofia Neaher, Caroline A Conway
Science Translational Medicine. 2024-01-03

Abstracts/Posters

Talazoparib Treatment Preferentially Depletes Cohesin-Mutant Clones in New In Vivo Models of Cohesin-Mutant Myeloid Diseases
Zuzana Tothova, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

A Community of ResearchersDecember 18th, 2020
Dana-Farber Receives $5 Million Gift to Create the Edward P. Evans Center for MDSSeptember 16th, 2019
Dana-Farber Physician Zuzana Tothova Receives Doris Duke Foundation Paragon Award for Research ExcellenceNovember 24th, 2023